Literature DB >> 12521563

Current Complementary and Alternative Therapies for Multiple Sclerosis.

Allen C. Bowling1, Thomas M. Stewart.   

Abstract

The use of complementary and alternative medicine (CAM) appears to be high in the general population and in patients with multiple sclerosis (MS). There are no diets or dietary supplements that are definitely effective in altering the disease course in MS. However, diets and dietary supplements that increase the intake of polyunsaturated fatty acids may produce mildly beneficial effects. Because these approaches are not definitely effective, they may be of limited interest to physicians and other conventional health providers. In contrast, for patients with MS, these interventions may be of considerable interest, because they may be mildly effective and are inexpensive and relatively safe. Vitamin D, ginkgo biloba, cannabinoids, and Padma 28 produce immunomodulatory actions and therapeutic effects in experimental autoimmune encephalomyelitis. However, for these compounds, there are not enough clinical trial data or safety information to support their use as disease-modifying therapies. The role of antioxidant compounds in MS is unclear. There is no evidence that vitamin B(12) supplementation or gluten-free diets are effective MS therapies. Conventional health providers can play an important role in the care of MS patients by being open to discuss CAM therapies and by providing objective MS-relevant CAM information.

Entities:  

Year:  2003        PMID: 12521563     DOI: 10.1007/s11940-003-0022-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  54 in total

Review 1.  Dietary fatty acids and lymphocyte functions.

Authors:  P C Calder
Journal:  Proc Nutr Soc       Date:  1998-11       Impact factor: 6.297

2.  Lipids and multiple sclerosis.

Authors:  D Bates
Journal:  Biochem Soc Trans       Date:  1989-04       Impact factor: 5.407

3.  Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.

Authors:  A Achiron; S Miron; V Lavie; R Margalit; A Biegon
Journal:  J Neuroimmunol       Date:  2000-01-03       Impact factor: 3.478

Review 4.  Treatment and management of multiple sclerosis.

Authors:  L A Liversedge
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

5.  Is there a role for gluten-free diets in multiple sclerosis?

Authors:  D C Hewson
Journal:  Hum Nutr Appl Nutr       Date:  1984-12

6.  Fish oil supplementation improves visual evoked potentials in children with phenylketonuria.

Authors:  S Beblo; H Reinhardt; A C Muntau; W Mueller-Felber; A A Roscher; B Koletzko
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

7.  High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium.

Authors:  J Mai; P S Sørensen; J C Hansen
Journal:  Biol Trace Elem Res       Date:  1990-02       Impact factor: 3.738

8.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

9.  MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders.

Authors:  M Martinez; E Vazquez
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

10.  Cannabinoids control spasticity and tremor in a multiple sclerosis model.

Authors:  D Baker; G Pryce; J L Croxford; P Brown; R G Pertwee; J W Huffman; L Layward
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

View more
  9 in total

Review 1.  Complementary and alternative medicine: is there a role in multiple sclerosis?

Authors:  Vijayshree Yadav; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Authors:  Annett Apel; Brigitte Greim; Nicolaus König; Uwe K Zettl
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

Review 3.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

Review 4.  [Diet and multiple sclerosis].

Authors:  S Schwarz; H Leweling
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

5.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

Review 6.  Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.

Authors:  Goli Arji; Hossein Rezaeizadeh; Abdolrreza Naser Moghadasi; Mohammad Ali Sahraian; Mehrdad Karimi; Mojtaba Alizadeh
Journal:  Acta Neurol Belg       Date:  2022-01-21       Impact factor: 2.396

7.  Dietary interventions for multiple sclerosis-related outcomes.

Authors:  Natalie E Parks; Caitlin S Jackson-Tarlton; Laura Vacchi; Roah Merdad; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2020-05-19

8.  Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.

Authors:  L Skovgaard; P H Nicolajsen; E Pedersen; M Kant; S Fredrikson; M Verhoef; D W Meyrowitsch
Journal:  Autoimmune Dis       Date:  2012-12-11

Review 9.  Uses of complementary and alternative medicine in multiple sclerosis.

Authors:  Foroogh Namjooyan; Rahil Ghanavati; Nastaran Majdinasab; Shiva Jokari; Mohammad Janbozorgi
Journal:  J Tradit Complement Med       Date:  2014-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.